BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, December 6, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

June 7, 2007

View Archived Issues

Paroxetine does not significantly affect paliperidone pharmacokinetics

Read More

Novel oral CCK2 receptor antagonists profiled at Johnson & Johnson

Read More

Novel agents for treating endocrine-related disorders disclosed in recent patent literature

Read More

Novel therapeutic agents for respiratory disorders disclosed in recent Amira patent

Read More

New clinical data on aliskiren in hypertension

Read More

Metabasis presents preclinical results on its liver-targeted thyroid receptor agonist MB-07811

Read More

Rexin-G cleared for U.S. trials in breast cancer and sarcoma

Read More

France grants ATU for Thalidomide in elderly with untreated multiple myeloma

Read More

GSK's novel androgen receptor modulator improves muscle strength in orchidectomized animals

Read More

AstraZeneca completes successful tender offer for MedImmune shares

Read More

SPA agreement for pivotal study of Zybrestat in anaplastic thyroid cancer

Read More

Oral Hsp90 inhibitor SNX-5422 begins phase I trial

Read More

GlaxoSmithKline advances calcilytics program in osteoporosis

Read More

Transition Therapeutics acquires remaining shares of NeuroMedix

Read More

Constab's lead compound shows promise in metastatic colorectal cancer

Read More

Development activities continue for MK-2295

Read More

Corautus Genetics stockholders approve merger with VIA Pharmaceuticals

Read More

FDA places Telcyta trials on clinical hold

Read More

Pharmacokinetic, safety and efficacy data presented for PharmaMar's Zalypsis

Read More

STA-4783 + paclitaxel shows promise in metastatic melanoma

Read More

Vernakalant (iv) effective in conversion of atrial fibrillation in ACT 2 study

Read More

EVT-201 demonstrates robust effects on sleep onset and maintenance

Read More

Reolysin shows antitumor activity in advanced and metastatic cancers

Read More

Fractionated dose schedule and addition of methylphenidate reduces MLN-8054-related somnolence

Read More

Favorable interim results for Amgen anti-HGF antibody

Read More

R&D highlights from BIO 2007 in Boston: York Pharma

Read More

Doripenem filed for treatment of nosocomial pneumonia

Read More

Norditropin approved for short stature in children with Noonan syndrome

Read More

Altargo approved in E.U. for impetigo and other skin infections

Read More

Japanese launch for Somavert in acromegalia

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 5, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 5, 2025.
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • Art concept for gene therapy

    Gene therapies aim for the big goal of edits in vivo

    BioWorld Science
    The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing